In many countries, short-acting β 2-agonist inhalers have traditionally been coloured blue. This inhaled therapy has also conventionally been known as a ‘reliever’ by patients and healthcare ...

Medics have warned that some asthma sufferers using blue inhalers could be putting their health at risk. More than seven million Brits are living with asthma, according to Asthma and Lung UK. An ...

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over, rather than the ...

“Be wary of [SABA] overuse. It is for when the patient has poor control of their symptoms, but should not be used for routine treatment,” said Holmes, a general practitioner (GP) partner at The Park ...

Children who use a lot of blue reliever inhalers are several times more likely to have severe asthma attacks A new study is offering children with asthma an enhanced check-up to see whether it can ...

This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...

Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...

She says the new medication is harder to use ...

Asthma + Lung UK says more needs to be done to prevent the overuse of inhalers.

Add Yahoo as a preferred source to see more of our stories on Google. Children who use a lot of blue reliever inhalers are several times more likely to have severe asthma attacks [BBC] A new study is ...

A new study is offering children with asthma an enhanced check-up to see whether it can bring down the overuse of inhalers. The Prescription Alerts for Reliever Inhalers in Children (PARC) study at ...